Biomedical subjects

E Tran

Publications and source records attributed to E Tran.

15 recordsLinked to original sources

PubMed2005

[Acute myocardial infarction and MRI: a comparison of infarct size by MRI and peak creatine kinase after a first episode].

AIM: To compare the assessment of infarct size using MRI and peak CK value. POPULATION AND METHODS: 16 patients presenting with a first MI and seriall measurement of CK underwent gadolinium-enhanced MRI. RESULTS: A significant correlation was observed between both estimates of infarct size (r=0.56, p=0.0025). In addition, an inverse correlation was found between residual viability and peak CK (r=-0.51; p=0.043). CONCLUSION: After a first episode of MI, infarct size estimate by MRI correlates with that determined by peak CK measurement.

Aged↗

PubMed2004

Electron exchange between two electrodes mediated by two electroactive adsorbates.

Experimental data for electron exchange between two electrodes covered by electroactive films are presented and discussed in terms of the Gerischer model. A model Hamiltonian is proposed for such indirect electron exchange involving two intermediate species. Explicit model calculations are performed for the case in which the coupling between the two adsorbates is weak and determines the overall rate. The calculations agree well with the experimental data, and can be used to determine the energy of reorganization associated with the electron transfer.

Journal Article↗

PubMed2004

Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is one of the most common malignancies in Southeast Asia. Hyperphosphorylation of retinoblastoma (pRB) by cyclin/CDKs in G1/S transition is required for its inactivation and cell cycle progression. In the present study, we report that phosphorylation of pRB at Ser780 and Ser795 was detected in 71% (33 of 46) and 63% (29 of 46) of HCCs examined respectively. pRB protein was undetectable in 13% (6 of 46) of HCCs examined. Phosphorylated pRB was localized in the nuclei of hepatocarcinoma cells. Benign hepatocytes exhibited very weakly or no nuclear staining for phosphorylated pRB. Over-expression of E2F-1, cyclin D1, Cdk-2, Cdk-4 and cyclin A was found in 64% (30 of 46), 43% (26 of 46), 28% (11 of 46), 71% (33 of 46) and 63% (29 of 46) of HCCs examined respectively and this was correlated with elevation of ERK. Treatment of HepG2 cells with MEK1/2 inhibitor U0126 resulted in cell cycle arrest, downregulation of cyclin D1 and Cdk-2 expression and inhibition of pRB phosphorylation at Ser780 and Ser795. Ectopic expression of activated MEK1 in HepG2 cells increased cyclin D1 and Cdk-2 expression, phosphorylation of pRB at Ser780 and Ser795, and percentage of cells in S phase. Our data indicate that activated ERK plays an important role in cyclin D1 and Cdk-2 expression and phosphorylation of pRB at Ser780 and Ser795 in liver cancer cells.

CDC2-CDC28 Kinases↗

PubMed2003

The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.

Dietary phytochemicals have been shown to be protective against various types of cancers. However, the precise underlying protective mechanisms are poorly understood. In the present study, we report that treatment of A549 cells with quercetin resulted in a dose-dependent reduction in cell viability and DNA synthesis with the rate of apoptosis equivalent to 1.2 +/- 0.8, 6.3 +/- 0.9, 16.5 +/- 1.5, 36.4 +/- 2.6 and 42.5 +/- 5.8% on treatment with 0.1% dimethylsulfoxide, 14.5, 29.0, 43.5 and 58.0 micro M quercetin, respectively. Concomitantly, quercetin treatments led to a 1.1-, 1.1-, 2.5- and 3.5-fold increase in Bax. Similar elevations were also observed in Bad, which increased 1.1-, 2.1-, 2.2- and 2.3-fold, respectively, as compared with control. While Bcl-2 was decreased by 30%, Bcl-x(L) was elevated in a dose-dependent fashion. Quercetin also induced the cleavage of caspase-3, caspase-7 and PARP (poly ADP-ribose polymerase). While Akt-1 and phosphorylated Akt-1 were inhibited, the extracellular signal-regulated kinase (ERK) was phosphorylated following quercetin treatment in a dose-dependent fashion. Phosphorylation of ERK and c-Jun occurred at 3 h and was sustained over 14 h. Phosphorylation of MEK1/2 was increased in concordance with ERK activation. Quercetin-induced phosphorylation of c-Jun N-terminal kinase (JNK) and cleavage of caspase-3 occurred 6 h after quercetin exposure and before cleavage of caspase-7 and PARP was detected. Inhibition of MEK1/2 but not PI-3 kinase, p38 kinase or JNK abolished quercetin-induced phosphorylation of c-Jun, cleavage of caspase-3 and -7, cleavage of PARP and apoptosis. Inhibition of caspase activation completely blocked quercetin-induced apoptosis. Expression of constitutively activated MEK1 in A549 cells led to activation of caspase-3 and apoptosis. The results suggest that in addition to inactivation of Akt-1 and alteration in the expression of the Bcl-2 family of proteins, activation of MEK-ERK is required for quercetin-induced apoptosis in A549 lung carcinoma cells.

Apoptosis↗

PubMed2003

Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK.

A vast variety of naturally occurring substances have been shown to protect against experimental carcinogenesis and an increasing amount of evidence suggests that kaempferol may have cancer chemopreventative properties. However, the precise underlying protective mechanisms are poorly understood. To elucidate these mechanisms, we challenged human lung cancer cell line A549 with kaempferol and investigated its effects upon cellular growth and signal transduction pathways. Treatment of A549 cells with kaempferol resulted in a dose- and time-dependent reduction in cell viability and DNA synthesis with the rate of apoptosis equivalent to 0.9+/-0.5, 5.2+/-1.5, 16.8+/-2.0, 25.4+/-2.6, and 37.8+/-4.5% on treatment with 0, 17.5, 35.0, 52.5, and 70.0 microM kaempferol, respectively. Concomitantly, kaempferol treatments led to a 1.2-, 2.7-, 3.3-, and 3.4-fold increase in Bax. Similar elevations were also observed in Bad which increased 1.2-, 3.3-, 3.7-, and 4.7-fold, respectively, as compared to control. Bcl-2 and Bcl-xL expression were inhibited in a dose-dependent fashion. While the Akt-1 and phosphorylated Akt-1 were inhibited, the mitogen-activated protein kinase (MAPK) was activated upon kaempferol treatment. Kaempferol induced apoptosis was associated with the cleavage of caspase-7 and poly ADP-ribose polymerase (PARP). Inhibition of MEK1/2 but not PI-3 kinase blocked kaempferol-induced cleavage of caspase-7, PARP cleavage, and apoptosis. The results suggest that inactivation of Akt-1 and alteration of Bcl-2 family of proteins are not sufficient for kaempferol to induce apoptosis and activation of MEK-MAPK is a requirement for kaempferol-induced cell death machinery in A549 cells.

Antineoplastic Agents↗

PubMed2003

Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids.

BACKGROUND: Keloids are characterized by abnormal proliferation of fibroblasts and overproduction of collagen. Insulin-like growth factor (IGF)-I is mitogenic for fibroblasts and a stimulatory factor for collagen synthesis. OBJECTIVES: We have assessed the in vitro effects of quercetin on proliferation, collagen synthesis and the expression of the IGF system in keloid-derived fibroblasts. METHODS: Fibroblasts were isolated from earlobe keloids and exposed to quercetin at different concentrations. The inhibitory effects of quercetin on fibroblast proliferation were assayed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Western and Northern blot analyses. RESULTS: Quercetin inhibited keloid fibroblast (KF) proliferation in a dose-dependent manner. Significant growth inhibition was observed on day 2 of culture. The dose required for 50% growth inhibition was approximately 25 microg mL-1. Collagen 1 expression was significantly decreased while collagen 3 was almost undetectable following quercetin treatment. Basal levels of IGF-I receptor (IGF-IR) beta subunits, p85 subunit of phosphatidylinositol 3-kinase, c-Raf, phospho-Raf-1, phospho-MEK 1/2, phospho-mitogen-activated protein kinase, phospho-Elk-1 and phospho-Akt-1 were significantly reduced when KF cells were exposed to quercetin for 24 h. Blocking IGF-IR activity with IGF-IR antibody or neutralizing endogenous IGF-I activity with IGF-I antibody led to significant growth inhibition suggesting the role of IGF-I in regulation of KF proliferation. CONCLUSIONS: Because the IGF system plays an important part in fibroblast cell proliferation and collagen production, the described activities of quercetin on the IGF system and collagen expression may provide a novel approach for the use of quercetin in treatment and/or prevention of hypertrophic scar and keloid.

Blotting, Northern↗

PubMed2001

Thermal activation of hydrocarbon C-H bonds by tungsten alkylidene complexes.

Thermal activation of CpW(NO)(CH(2)CMe(3))(2) (1) in neat hydrocarbon solutions transiently generates the neopentylidene complex, CpW(NO)(=CHCMe(3)) (A), which subsequently activates solvent C-H bonds. For example, the thermolysis of 1 in tetramethylsilane and perdeuteriotetramethylsilane results in the clean formation of CpW(NO)(CH(2)CMe(3))(CH(2)SiMe(3)) (2) and CpW(NO)(CHDCMe(3))[CD(2)Si(CD(3))(3)] (2-d(12)), respectively, in virtually quantitative yields. The neopentylidene intermediate A can be trapped by PMe(3) to obtain CpW(NO)(=CHCMe(3))(PMe(3)) in two isomeric forms (4a-b), and in benzene, 1 cleanly forms the phenyl complex CpW(NO)(CH(2)CMe(3))(C(6)H(5)) (5). Kinetic and mechanistic studies indicate that the C-H activation chemistry derived from 1 proceeds through two distinct steps, namely, (1) rate-determining intramolecular alpha-H elimination of neopentane from 1 to form A and (2) 1,2-cis addition of a substrate C-H bond across the W=C linkage in A. The thermolysis of 1 in cyclohexane in the presence of PMe(3) yields 4a-b as well as the olefin complex CpW(NO)(eta(2)-cyclohexene)(PMe(3)) (6). In contrast, methylcyclohexane and ethylcyclohexane afford principally the allyl hydride complexes CpW(NO)(eta(3)-C(7)H(11))(H) (7a-b) and CpW(NO)(eta(3)-C(8)H(13))(H) (8a-b), respectively, under identical experimental conditions. The thermolysis of 1 in toluene affords a surprisingly complex mixture of six products. The two major products are the neopentyl aryl complexes, CpW(NO)(CH(2)CMe(3))(C(6)H(4)-3-Me) (9a) and CpW(NO)(CH(2)CMe(3))(C(6)H(4)-4-Me) (9b), in approximately 47 and 33% yields. Of the other four products, one is the aryl isomer of 9a-b, namely, CpW(NO)(CH(2)CMe(3))(C(6)H(4)-2-Me) (9c) ( approximately 1%). The remaining three products all arise from the incorporation of two molecules of toluene; namely, CpW(NO)(CH(2)C(6)H(5))(C(6)H(4)-3-Me) (11a; approximately 12%), CpW(NO)(CH(2)C(6)H(5))(C(6)H(4)-4-Me) (11b; approximately 6%), and CpW(NO)(CH(2)C(6)H(5))(2) (10; approximately 1%). It has been demonstrated that the formation of complexes 10 and 11a-b involves the transient formation of CpW(NO)(CH(2)CMe(3))(CH(2)C(6)H(5)) (12), the product of toluene activation at the methyl position, which reductively eliminates neopentane to generate the C-H activating benzylidene complex CpW(NO)(=CHC(6)H(5)) (B). Consistently, the thermolysis of independently prepared 12 in benzene and benzene-d(6) affords CpW(NO)(CH(2)C(6)H(5))(C(6)H(5)) (13) and CpW(NO)(CHDC(6)H(5))(C(6)D(5)) (13-d(6)), respectively, in addition to free neopentane. Intermediate B can also be trapped by PMe(3) to obtain the adducts CpW(NO)(=CHC(6)H(5))(PMe(3)) (14a-b) in two rotameric forms. From their reactions with toluene, it can be deduced that both alkylidene intermediates A and B exhibit a preference for activating the stronger aryl sp(2) C-H bonds. The C-H activating ability of B also encompasses aliphatic substrates as well as it reacts with tetramethylsilane and cyclohexanes in a manner similar to that summarized above for A. All new complexes have been characterized by conventional spectroscopic methods, and the solid-state molecular structures of 4a, 6, 7a, 8a, and 14a have been established by X-ray diffraction methods.

Journal Article↗

PubMed2001

Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780.

The antiestrogen, ICI 182780 (ICI) proves to be clinically useful for the treatment of estrogen receptor positive breast tumours. We report the assessment of the in vivo and in vitro effects of ICI on apoptosis of breast epithelial cells. In vivo, administration of rats with ICI for 3 weeks resulted in a reduction in the size of the lobular structures with the rate of mammary epithelial apoptosis equivalent to 10, 35 and 45% on treatment with 1, 1.5 and 2 mg ICI per kg body weight, respectively. Concomitantly, these treatment led to a 2.0-, 2.2- and 2.5-fold increase in Bax. Similar elevations were also observed in Bad levels which increased 1.7-, 2.6- and 2.7-fold respectively in the ICI treatment as compared to controls. This also resulted in a dose dependent decrease in Bcl-2 and Bcl-xL protein expressions. Growth inhibition and induction of apoptosis were also observed in the MCF-7 cells following in vitro treatment with ICI. This is closely associated with [1] the down-regulation of Bcl-2 and Bcl-xL proteins and [2] upregulation of Bax and Bad, whose gene products are known to be involved the regulation of apoptosis in mammalian cells. Stable over-expression of Bcl-2 resulted in protection of MCF-7 cells from apoptosis and growth inhibitory effects of ICI. Conversely, reduction of Bcl-2 by antisense transfection make MCF-7 cells more sensitive to ICI-induced growth inhibition and apoptosis. These findings suggest that modulation of Bax, Bcl-xL, Bcl-2 and Bad proteins by ICI may be, in part, responsible for the anti-proliferative and apoptotic effect of ICI seen clinically and in animal models.

Animals↗

PubMed2001

Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary.

A complementary DNA, uterine-ovarian-specific gene 44 (UO-44), has been isolated from tamoxifen-induced rat uterine complementary DNA library using differential display techniques. UO-44 transcripts are found to be abundant in the uterus and ovary. UO-44 gene expression in the uterus is strictly regulated by estrogens, tamoxifen, and GH, whereas the pure antiestrogen ICI 182780 is inhibitory. Treatment of ovariectomized rats and hypophysectomized rats with tamoxifen and GH, respectively, resulted in up-regulation of UO-44 expression in a dose-dependent manner. In situ hybridization revealed that UO-44 gene expression was restricted to the luminal and glandular epithelial cells of the uterus and to granulosa cells of medium-size ovarian follicles. Transfection studies showed that UO-44 was a membrane-associated protein. Because estrogens, tamoxifen, and GH are stimulators of uterine luminal epithelial cell growth in vivo, UO-44 protein may serve as a mediator of the effect of these compounds in inducing epithelial proliferation and differentiation in these tissues.

Animals↗

PubMed2000

Flow-cytometric method for the quantitation of the Fc function of intravenous immunoglobulin preparations.

OBJECTIVES: We have developed and optimised a new flow-cytometric method for the measurement of the Fc function of intravenous immunoglobulin (IVIg) preparations, which is important in predicting the effector function of immunoglobulin (Ig) in such preparations. MATERIALS AND METHODS: Ig was bound to a monocytic cell line, THP-1 with Fc gammaRI and Fc gammaRII cell surface receptors, and the bound Ig detected by FITC-conjugated F(ab)2 fragment of rabbit anti-human IgG. RESULTS: Validation studies showed that Ig bound to the cell line through the Fc portion. The method detected alterations in Fc function caused by reduction with dithiothreitol or by storage. The method was reproducible (CV<11%) and a limited comparison study showed that it correlated with the European Pharmacopoeia reference method. CONCLUSIONS: This technically simple method is suitable for the quantitation of the Fc function of Ig preparations.

Antibodies, Monoclonal↗

PubMed1998

Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.

In this study the use of collagen-binding assay, recently recommended by the European Pharmacopoeia for the characterization of Factor VIII/von Willebrand Factor (FVIII/vWF) concentrates was investigated. The collagen-binding assay was optimized to decrease reagent variability and, to allow for interlaboratory comparison, standardized against the third WHO International Plasma Standard for vWF and factor VIII, with the assumption that 1 unit of vWF antigen = 1 unit of collagen binding activity. A study of clinical samples of patients with von Willebrand's disease established that a ratio of vWF antigen; Collagen-binding activity <1.4 was associated with normal multimeric distribution and a ratio >3.7 was associated with loss of high molecular weight multimers and a decrease in biological activity. The collagen-binding assay of vWF was used to monitor changes in the biological activity of vWF during the manufacture of FVIII concentrates. Two commonly used industrial procedures using either glycine/NaCl precipitation or ion exchanges with TSK DEAE column chromatography were investigated. Samples taken at individual stages in the purification of FVIII concentrates, at the laboratory and industrial scale, were monitored using FVIII coagulant activity:vWF antigen ratio, Collagen-binding activity:vWF antigen ratio, and sodium dodecyl sulfate-agarose vWF multimeric analysis. All three parameters showed a retention of multimeric structure and biological activity during manufacture, to yield products which were clinically relevant in the treatment of von Willebrand's diseases.

Collagen↗

PubMed1998

Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE.

The cytokine interferon-gamma (IFNgamma) is implicated in the induction of acute CNS inflammation, but it is less clear what role if any IFNgamma plays in progression to chronic demyelination and neurological deficit. To address this issue, we have expressed IFNgamma in myelinating oligodendrocytes of transgenic mice. MHC I immunostaining and iNOS mRNA were upregulated in their CNS, but such transgenic mice showed no spontaneous CNS inflammation or demyelination, and the incidence, severity, and histopathology of experimental autoimmune encephalomyelitis (EAE) were similar to nontransgenic controls. In contrast to control mice, which remit from EAE with resolution of glial reactivity and leukocytic infiltration, transgenics showed chronic neurological deficits. While activated microglia/macrophages persisted in demyelinating lesions for over 100 days, CD4(+) T lymphocytes were no longer present in CNS. IFNgamma therefore may play a role in chronic demyelination and long-term disability following the induction of demyelinating disease. Because IFNgamma may have neural as well as immune-infiltrating origins, these findings generate a new perspective on its role in the CNS.

Animals↗

PubMed1997

Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis.

Experimental allergic encephalomyelitis (EAE) was induced in SJL/J mice by adoptive transfer of MBP-reactive T cells in order to investigate the role of astrocytes in pathology. GFAP protein and mRNA expression (analyzed using semiquantitative Western blot and RT-PCR techniques) were upregulated in the spinal cord of mice, which had developed a complete paralysis of hind- and fore-limbs and tail (grade 4 EAE), thus establishing that reactive gliosis occurred under these experimental conditions. Within the same samples and using similar techniques, we found that glutamine synthetase (GS) and glutamate dehydrogenase (GDH) expression were dramatically reduced. These two astrocytic enzymes are responsible for degradation of glutamate, the most abundant excitatory neurotransmitter in the brain. Since elevated levels of glutamate may be neurotoxic, we propose that the decreased capacity of astrocytes to metabolize glutamate may contribute to EAE pathology.

Adoptive Transfer↗

PubMed1997

Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations.

Anticomplementary activity (ACA) of aggregates in intravenous immunoglobulin preparations (IVIG) was investigated using the modified Kabat and Meyer classical complement consumption method recommended by the European Pharmacopoeia and a C1q-coated microtitre enzyme-linked immunosorbent assay (ELISA). The physical characteristics of aggregates were found to affect complement binding. Aggregates formed by heating IVIG preparations at acid pH bound complement poorly, while aggregates formed by heating IVIG at neutral pH showed high ACA. This suggests that analysis of complement binding capacity provides a level of aggregate characterization of aggregates which is additional to quantitation by High-performance liquid chromatography ((HPLC). The correlation (r = 0.98) between the two tests was good when aggregates formed at neutral pH were compared, but decreased (r = 0.57) when aggregates formed at acid pH were included. A comparison of the results showed that there were no significant differences in the classification of aggregates with acceptable/unacceptable (i.e. pass/fail outcome) values of ACA. Between assay variation (CV = 7.6%) was lower in the ELISA test compared with the complement consumption assay (where percentage binding varied from 78.9% to 100%). Both assays are justified for the evaluation of ACA in therapeutic IVIG. The ELISA had the advantage in being more precise, less dependent on reagent source and requiring less technical expertise.

Complement Inactivator Proteins↗

PubMedDate not supplied

Immune cell entry to the CNS--a focus for immunoregulation of EAE.

T-cell-derived cytokines are therefore individually unnecessary and collectively insufficient for microglial response. This somewhat provocative interpretation does not exclude a role for T-cell cytokines in induction of a microglial response in EAE, but it may be easier to show a non-requirement then to prove such a role. The point that emerges is that cytokine production in the CNS parenchyma is itself dependent on the prior infiltration of immune cells, and that without immune cell entry, EAE does not occur. This identifies events at the BBB, and in particular in the perivascular space, as critical immunoregulatory events in development and progression of EAE.

Animals↗